Mecanismos celulares y moleculares de la enfermedad cerebrovascular isquémica

Revista Cubana de Medicina

Volumn 43, Issue 4, 2004, Pages

  Guevara García, Mariela ^a   Rodríguez, Raisa ^a   Álvarez León, Alina ^a   Riaño Montalvo, Annia ^a   Rodríguez Rodríguez, Pedro Camilo ^a  

^a Centro de Quimica Farmaceutica   (Cuba)

Author keywords

Cellular mechanisms; Free radicals; Ischemic cascade; Ischemic cebrovascular disease; Molecular mechanisms; Neurotransmissors

Indexed keywords

EID: 36349023523     PISSN: 00347523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Neumar RW. Molecular mechanisms of ischemic neuronal injury. Ann Emerg Med 2000;36:483-506.
2. Touzani O, Roussel S, MacKenize E. The ischemic penumbra. Current Opinion in Neurology 2001;14:83-88.
3. Choi DW. Cerebral hypoxia: some new approaches and unanswered questions. J Neurosci 1990;10:2493-2501.
4. Baron J. Mapping the ischemic penumbra with PET: implications for acute stroke treatment. Cerebrovasc Dis 1999;9:193-201.
5. Kaufmann AM, Firlik AD, Fukui MB. Ischemic core and penumbra in human stroke. Stroke 1999;9:193-201.
6. Hill MD, Hachinski V. Stroke treatment: Time is brain. Lancet 1998;352 (Suppl): 10-14.
7. Maiese K. Hypoxic-ischemic encephalopathy. En: Arbor Publishing Corp. Fourth Edition. 1998.
8. Kristian T, Siesjo BK. Calcium-related damage in ischemia. Life Sci 1996;59:357-67.
9. Harris RJ, Symon L, Branston NM, Bayhan M. Changes in extracellular calcium activity in cerebral ischemia. J Cere Blood Flow Metab 1981;1:203-09.
10. Ueda Y, Obrenovitch TP, Lok SY, Sarna GS, Symon L. Changes in extracellular glutamate concentration produced in the rat striatum by repeated ischemia. Stroke 1992;23:1125-31.
11. Choi DW. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci 1988;11:465-9.
12. Choi DW. Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci 1995;18:58-60.
13. Halliwell B, Gutteridge JM. Oxygen toxicity, oxigen radicals, transition metals and disease. Biochem J 1984;21:1-14.
14. Wei EP, Christman CW, Kontosw HA, Povlishock JT. Effects of oxygen radicals on cerebral aerterioles. Am J Physiol 1985;248:H157-H162.
15. Schmidley JW. Free radicals in central nervous system ischemia. Stroke 1990;21:1086-1090.
16. Asano T. Cerebral ischemia and free radical. No To Shinkei 2003;55(3):201-13.
17. Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 2003 May;4(5):399-415.}
18. Virag L, Szabo E, Gergely P, Szabo C. Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention. Toxicol Lett 2003 Apr 11;140-141:113-24.
19. Liu S, Liu M, Peterson S, Miyake M, Vallyathan V, Liu KJ. Hydroxyl radical formation is greater in striatal core than in penumbra in a rat model of ischemic stroke. J Neurosci Res 2003 Mar 15;71(6):882-8.
20. Kim JS. Cytokines and adhesion molecules in stroke and related diseases. J Neurol Sci 1996;137:69-78.
21. Buttini M, Sauder A, Boddeke HWGM. Induction of interleukin-11111mRNA after focal cerebral ischemia in the rat. Mol Brain Res 1994;23:126-34.
22. Yaabuuchi K, Minami K, Katsumata A, Satoh M. An in situ hybridization study on interleukin-1mRNA induced by transient forebrain ischemia in the rat brain. Mol Brain Res 1994;26;135-42.
23. Szaflarski J, Burtrum D, Silverstein FS. Cerebral hypoxia-ischemia stimulates cytokine gene expression in perinatal rats. Stroke 1995;26:1093-100.
24. Yamasaki Y, Matsuura N, Scohzuhara H, Onodera H. Itoyama Y, Kogure K. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 1995;26:676-81.
25. Rotthwell NJ, Relton JK. Involvement of interleukin-1 and lipocortin-1 in ischemic brain damage. Cerebrovascular Brain Metab Rev 1993;5:178-98.
26. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated immflamation. N Engl J Med 1995;332:1351-1362.
27. Akopov SE, Simonian NA, Grigorian GS. Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage. Stroke 1996;27:1739-43.
28. Tarkowski E, Rosengren L, Blomstrand C, Wikkelsö C, Jensen C, Ekholm S, Tarkowski A. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 1995;26:1393-8.
29. Kim JS. Cytokines and adhesion molecules in stroke and related diseases. J Neurol Sci 1996;137:69-78.
30. Kostulas N, Kivisakk P, Huang Y, Matusevicius D, Kostulas V, Link H. Ischemic stroke is associated with a systemic increase of blood mononuclear cells expressing interleukin-8 mRNA. Stroke 1998;29:462-6.
31. Rost N. Plasma Concentration of C-Reactive Protein and Risk of Stroke and Transient Ischemic Attack. Stroke 2001;32:2575
32. Winquist RJ, Kerr S. Cerebral ischemia-reperfusion injury and adhesion. Neurology 1997;49 (suppl 4):S23-26.
33. Kochaneck PM, Hallenbeck JM. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 1992;23:1367-79.